We’re improving your experience!

×

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05845814
Title A Study of Efficacy and Safety of Pembrolizumab Plus Enfortumab Vedotin (EV) +/- Investigational Agents in First-Line Metastatic Urothelial Carcinoma (mUC) (MK-3475-04B/KEYMAKER-U04)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | ISR | GBR | FRA | ESP | CAN | AUS

Facility Status City State Zip Country Details
Moores Cancer Center ( Site 3028) La Jolla California 92093 United States Details
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 3045) Orange California 92868 United States Details
Anschutz Cancer Pavilion ( Site 3017) Aurora Colorado 80045 United States Details
Emory University School of Medicine ( Site 3043) Atlanta Georgia 30322 United States Details
Indiana University Melvin and Bren Simon Cancer Center ( Site 3011) Indianapolis Indiana 46202 United States Details
Washington University School of Medicine ( Site 3038) Saint Louis Missouri 63110 United States Details
Icahn School of Medicine at Mount Sinai ( Site 3018) New York New York 10029 United States Details
Memorial Sloan Kettering Cancer Center ( Site 3031) New York New York 10065 United States Details
Cleveland Clinic-Taussig Cancer Center ( Site 3036) Cleveland Ohio 44195 United States Details
UPMC Hillman Cancer Center ( Site 3014) Pittsburgh Pennsylvania 15232 United States Details
Huntsman Cancer Institute-HCI Clinical Trials Office ( Site 3041) Salt Lake City Utah 84112 United States Details
Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si Brisbane Queensland 4029 Australia Details
Austin Health-Cancer Clinical Trials Centre ( Site 3950) Heidelberg Victoria 3084 Australia Details
The Ottawa Hospital - General Campus-The Ottawa Hospital Cancer Centre ( Site 3105) Ottawa Ontario K1H 8L6 Canada Details
Sunnybrook Research Institute - Odette Cancer Centre ( Site 3108) Toronto Ontario M4N 3M5 Canada Details
Princess Margaret Cancer Centre ( Site 3106) Toronto Ontario M5G 2M9 Canada Details
FALP-UIDO ( Site 3151) Santiago Region M. De Santiago 7500921 Chile Details
Bradfordhill-Clinical Area ( Site 3155) Santiago Region M. De Santiago 8420383 Chile Details
ONCOCENTRO APYS-ACEREY ( Site 3158) Viña del Mar Valparaiso 2520598 Chile Details
Bradford Hill Norte ( Site 3152) Antofagasta 1240000 Chile Details
CHU de Bordeaux Hop St ANDRE ( Site 3607) Bordeaux Aquitaine 33075 France Details
Centre Georges François Leclerc-Centre de recherche clinique ( Site 3608) Dijon Cote-d Or 21079 France Details
Oncopole Claudius Regaud ( Site 3610) Toulouse Haute-Garonne 31059 France Details
Hôpital Européen Georges Pompidou ( Site 3605) Paris Ile-de-France 75015 France Details
centre hospitalier lyon sud ( Site 3606) Pierre-Bénite Rhone 69310 France Details
Rambam Health Care Campus-Oncology Division ( Site 3501) Haifa 3109601 Israel Details
Rabin Medical Center-Oncology ( Site 3504) Petah Tikva 4941492 Israel Details
Sheba Medical Center-ONCOLOGY ( Site 3503) Ramat Gan 5265601 Israel Details
Ospedale San Raffaele-Oncologia Medica ( Site 3403) Milano Lombardia 20132 Italy Details
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 3405) Milan Lombardia 20133 Italy Details
Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 3406) Napoli 80131 Italy Details
Severance Hospital, Yonsei University Health System-Medical oncology ( Site 3903) Seoul 03722 Korea, Republic of Details
Asan Medical Center-Department of Oncology ( Site 3901) Seoul 05505 Korea, Republic of Details
Samsung Medical Center ( Site 3902) Seoul 06351 Korea, Republic of Details
Maastricht UMC+ ( Site 3304) Maastricht Limburg 6229 HX Netherlands Details
Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL)-medical oncology ( Site 3302) Amsterdam Noord-Holland 1066 CX Netherlands Details
Erasmus Medisch Centrum-Medical Oncology ( Site 3303) Rotterdam Zuid-Holland 3015 GD Netherlands Details
Hospital Universitari Vall d'Hebron ( Site 3767) Barcelona 08035 Spain Details
Hospital Clinico San Carlos ( Site 3765) Madrid 28040 Spain Details
Chang Gung Memorial Hospital at Kaohsiung-Oncology and Hematology ( Site 3802) Kaohsiung 83301 Taiwan Details
National Cheng Kung University Hospital-Clinical Trial Center ( Site 3803) Tainan 704 Taiwan Details
National Taiwan University Hospital-Oncology ( Site 3801) Taipei 10002 Taiwan Details
St Bartholomew's Hospital-Centre for Experimental Cancer Medicine ( Site 3206) London London, City Of EC1A 7BE United Kingdom Details
ROYAL MARSDEN HOSPITAL (CHELSEA) ( Site 3201) London London, City Of SW3 6JJ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field